KRAS and pancreatic neoplasm: Furthermore, the transcription factor ONECUT2 was identified as a putative driver of early progression of pancreatic cancer whose role in the activation of the KRAS pathway was sufficient to induce acinar hyperplasia, although the neoplastic lesions developed focally (66).